Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer

作者
G. Fleischhack
出处
期刊:Journal of Antimicrobial Chemotherapy [Oxford University Press]
卷期号:47 (6): 841-853 被引量:92
标识
DOI:10.1093/jac/47.6.841
摘要

This trial assessed the efficacy and safety of meropenem versus ceftazidime as empirical monotherapy for febrile neutropenia in paediatric cancer patients. In a prospective randomized study, 172 evaluable febrile episodes in the meropenem arm and 170 episodes in the ceftazidime arm were analysed for the clinical and microbiological response dependent on the kind of infection. About half the episodes were classified as fever of unknown origin (FUO) and the remainder as microbiologically or clinically documented infections. The most frequently documented infections in both arms were bacteraemias (22.1 versus 26.5%), predominantly caused by Gram-positive organisms (57.9 versus 71.1%). The success rate of the initial monotherapy differed significantly between the two arms and was 55.8% in the meropenem and 40.0% in the ceftazidime arm (P = 0.003). In addition, a significantly longer duration of fever and of antimicrobial therapy was observed in the ceftazidime arm than in the meropenem arm (median 5 versus 4 days, P = 0.022, and 7 versus 6 days, P = 0.009, respectively). With respect to the kind of infection, differences between the two arms were significant only in episodes classified as FUO but not in documented infections. In both arms, side effects were minimal. Despite the greater response rate for meropenem in FUO, the fact that ceftazidime has been proven to be as effective as meropenem in documented infections in the present study suggests that both drugs are useful as empirical monotherapy in febrile paediatric cancer patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
典雅的纸飞机完成签到 ,获得积分10
1秒前
19863737023发布了新的文献求助10
1秒前
yu完成签到 ,获得积分10
1秒前
1秒前
2秒前
ksperate发布了新的文献求助10
3秒前
加油小Q完成签到,获得积分20
3秒前
不说话的变态劳工完成签到 ,获得积分10
4秒前
11完成签到 ,获得积分10
4秒前
4秒前
5秒前
李爱国的应助被执意采纳,获得10
5秒前
郭亲鹏发布了新的文献求助10
5秒前
MetaMysteria发布了新的文献求助10
6秒前
6秒前
7秒前
哈哈哈完成签到 ,获得积分10
7秒前
紫菜珍藏版完成签到 ,获得积分10
8秒前
小迪发布了新的文献求助10
9秒前
11秒前
pancake发布了新的文献求助20
13秒前
cdercder的应助被邓志昊采纳,获得10
14秒前
Cg完成签到,获得积分10
14秒前
15秒前
ding的应助被wjq_wind采纳,获得10
16秒前
ABS四星发布了新的文献求助10
17秒前
bkagyin的应助被外向的芒果采纳,获得10
17秒前
GIN的应助被忧心的妙之采纳,获得30
19秒前
李健的应助被酷盖不太冷采纳,获得10
19秒前
Reaper完成签到,获得积分20
20秒前
22秒前
必须发顶刊完成签到,获得积分10
22秒前
Akim的应助被邓文哲采纳,获得10
23秒前
23秒前
七七发布了新的文献求助10
24秒前
zzf完成签到 ,获得积分10
24秒前
Reaper发布了新的文献求助10
24秒前
qq完成签到 ,获得积分20
25秒前
25秒前
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192776
求助须知:如何正确求助?哪些是违规求助? 9579206
关于积分的说明 21864151
捐赠科研通 7792348
什么是DOI,文献DOI怎么找? 3437041
关于科研通互助平台的介绍 2560633
邀请新用户注册赠送积分活动 2483916